Your position:m.limatoxi.com>>EN>>EN>>Formulation>>Hengrui Pharmaceuticals innovative drug HRS-4357 injection has been approved for clinical use in prostate cancer>> article
Hengrui Pharmaceuticals innovative drug HRS-4357 injection has been approved for clinical use in prostate cancer
Editor:xuezhe Clicks:0Date:2023-7-12 14:29:48
Keyword:HRS-4357
Healthoo Information:
Hengrui Pharmaceuticals innovative drug HRS-4357 injection has been approved for clinical use in prostate cancer
E-mail:xuezhe@healthoo.com
Tel.:86-10-68032463
Our services:
China Im\Ex data service
Service fees of Chinese Vision
Our service items
Online information introduction
Monthly information
Relative Information
Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
Tel:+86-10-68032463
Baidu
map